Clinical Role - Hospital

Skidki-na-vse® is at the forefront of providing the latest clinical updates, patient counseling tools and innovative solutions to hospital pharmacists and reaches more than 200,000 pharmacy professionals in total.

Advice for Growing a Health System Specialty Pharmacy
A webinar held by Trellis Rx discussed actionable ways to establish a successful clinic-based specialty pharmacy approach.
 
National Alliance on Mental Illness Releases Free Online Class
NAMI Basics OnDemand is an adaptation of the in-person NAMI Basics, a free, 6-session education program for parents, caregivers, and other family who provide care for adolescents aged 22 years or younger who are experiencing mental health symptoms.
Skidki-na-vse Continuing Education™ Announces Keynote Speakers for Directions in Oncology Pharmacy™ Fall Conference Series
The keynote, Priming Pharmacists for Making an Impact in Oncology Value-Based Care, sets the stage for the entire conference and highlights how pharmacists are critical to the multidisciplinary team in providing value in patient-centered oncology care.
Study: Number of Drug
A new study by Prime Therapeutics LLC has shown a sharp increase in the number of drug "super spenders," defined by the researchers as members with pharmacy and medical drug therapy claims of $250,000 or more annually.
FDA Testing Ranitidine for NDMA Impurities
The FDA is continuing to test ranitidine products from multiple manufacturers following the discovery of impurities in low levels in some medicines, including Zantac.
NIH-Funded Research Centers Launched with Focus on Alzheimer Drug Development
The National Institute on Aging (NIA) has launched 2 new research centers, the Alzheimer Centers for the Discovery of New Medicines, designed to diversify and strengthen the Alzheimer disease drug development pipeline.
Health Scare Prompts Oprah to Promote Vaccines
Oprah Winfrey’s message is clear: the flu and pneumonia vaccines are important.
Litigation Against FDA Over Vasopressin is Resolved
Two lawsuits against the FDA have been resolved in a conclusion favorable to Endo International, which argued that vasporessin should be excluded from the agency’s compounding list.
 
Companies Settle Opioid-Related Litigation with 2 Ohio Counties
Johnson & Johnson and its Janssen Pharmaceutical Cos unit have agreed to a more than $10 million settlement, rather than allowing the matter go to federal trial.
Generic Fulvestrant Injection Launched for Breast Cancer Monotherapy in Post-Menopausal Women
Fulvestrant injection treats certain types of breast cancer in post-menopausal women who were not previously treated with endocrine therapy and as a combination for advanced or metastatic breast cancer.
ClarIDHy Trial: First Targeted Therapy to Improve Outcomes in Cholangiocarcinoma
Ivosidenib improved progression-free survival with a promising trend toward improved overall survival in patients with IDH1-mutated cholangiocarcinoma.
 
Overall Survival, PFS Data Reported for Apalutamide in Non-metastatic CRPC at ESMO
Apalutamide (Erleada) showed an overall survival benefit in patients with non-metastatic castration-resistant prostate cancer.
 
+ Load More